Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Urologic Cancers
UROLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials. -
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP. -
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future. -
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
UROLOGIC CANCERS NEWS
dd-MVAC Regimen ‘Should Be Gold Standard’ for Muscle-Invasive Bladder Cancer
Preoperative Blood Glucose Level Linked to Length of Stay After Nephrectomy for Renal Cell Carcinoma
A Number of Men May Stop Active Surveillance for Prostate Cancer
Keytruda Gets Full Approval for First-Line Advanced Urothelial Carcinoma
Stockholm3 Test May Aid Risk Prediction in Prostate Cancer Screening
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Urologic Cancers
Loading... 
Loading...